people

Canadian Red Cross opens appeal to help people impacted by Hurricane Melissa

OTTAWA, Oct. 28, 2025 (GLOBE NEWSWIRE) -- The Canadian Red Cross has launched the Hurricane Melissa Appeal to help those…

2 months ago

Total Investment of Approx. USD 11.6 Million in TB and NTD R&D Projects With Partners Including Fujifilm, Stop TB Partnership, and the Ohio State University

TOKYO, Oct. 29, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.73…

2 months ago

Ironwood Academy Launches to Redefine Financial Learning

New York, NY, Oct. 24, 2025 (GLOBE NEWSWIRE) -- How Is Ironwood Changing the Way People Learn Finance?In a world…

3 months ago

ACKO Drive Launches 99 Car Spa Offer

BENGALURU, India, Oct. 24, 2025 /PRNewswire/ -- ACKO Drive has launched an irresistible ₹99 Car Spa Offer that allows people…

3 months ago

LA28 celebrates 1,000 days to go with youth sports and Olympians

21 October 2025 - Marking 1,000 days to go until the LA28 Olympic Games begin, celebrations in the host city of Los Angeles…

3 months ago

Manipal Hospital Sarjapur Road Empowers Fitness Enthusiasts with CPR Skills and First-Aid Workshop

BENGALURU, India, Oct. 14, 2025 /PRNewswire/ -- With the growing emphasis on fitness and overall well-being, fitness enthusiasts do much…

3 months ago

Sanofi Hosts Regional Webinar on Protecting High-Risk Groups from Seasonal Influenza

Sanofi recently hosted a hybrid symposium titled "Safeguarding High-Risk Groups: The Importance of Flu Prevention and Effective Communication," bringing together…

3 months ago

At the World Congress of Neurology, WHO Outlines a Global Roadmap to Make Brain Health a Universal Reality

SEOUL, South Korea and LONDON, Oct. 15, 2025 /PRNewswire/ -- Neurological conditions now affect more than 40% of the population—over…

3 months ago

School Meals Save Lives and Strengthen Communities

On World Food Day, Education Cannot Wait calls for increased investment in school feeding programmes worldwide. NEW YORK, Oct. 16,…

3 months ago

Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss

Vamikibart is the first non-steroid targeted therapy designed to address inflammation driving UME and may offer a potential new treatment…

3 months ago